Bioharvest Sciences Inc
Change company Symbol lookup
Select an option...
CNVCF Bioharvest Sciences Inc
WRLD World Acceptance Corp
CWD CaliberCos Inc
LNTH Lantheus Holdings Inc
DFIN Donnelley Financial Solutions Inc
SY So-Young International Inc
GOTU Gaotu Techedu Inc
SGDVV Safe & Green Development Corp
GLBZ Glen Burnie Bancorp
PHAR Pharming Group NV
Go

Consumer Staples : Personal Care Products | Small Cap Growth
Based in Canada
Company profile

BioHarvest Sciences Inc. is a Canada-based biotech company. The Company has developed a patented bio-cell growth platform technology. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Nutraceuticals segment is engaged in research and development of science-based therapeutic solutions for the nutraceutical industry. The Pharmaceuticals segment is focused on research and development of plant cell-based Active Pharmaceutical Ingredients, which can assist in the treatment of specific medical indications. The Company’s nutraceutical superfruits product, VINIA, is a red grape powder consumed as a food that provides the benefits of red wine consumption but without the sugar and alcohol found in wine. The Company's Bio-Plant CELLicitation technology, which is used in the pharmaceutical cannabis industry to produce cannabis cells in a process that is controlled, consistent, aseptic, non-GMO, pesticide-free and chemical-free.

Price
Delayed
$0.1329
Day's Change
0.0029 (2.26%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.1329
Day's Low
0.1329
Volume
(Light)

Today's volume of 3,192 shares is on pace to be much lighter than CNVCF's 10-day average volume of 41,320 shares.

3,192

Company Profile

BioHarvest Sciences Inc. is a Canada-based biotech company. The Company has developed a patented bio-cell growth platform technology. The Company operates through two segments: Nutraceuticals and Pharmaceuticals. The Nutraceuticals segment is engaged in research and development of science-based therapeutic solutions for the nutraceutical industry. The Pharmaceuticals segment is focused on research and development of plant cell-based Active Pharmaceutical Ingredients, which can assist in the treatment of specific medical indications. The Company’s nutraceutical superfruits product, VINIA, is a red grape powder consumed as a food that provides the benefits of red wine consumption but without the sugar and alcohol found in wine. The Company's Bio-Plant CELLicitation technology, which is used in the pharmaceutical cannabis industry to produce cannabis cells in a process that is controlled, consistent, aseptic, non-GMO, pesticide-free and chemical-free.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
7.00x
Price/Book (MRQ)
--
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

No historic growth available.

Short Interest

No short interest available.

Share Information

CNVCF is in a share class of common stock
Float
322.3M
Shares Outstanding
478.7M
Institutions Holding Shares
--
--

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

No company officers listed.

Address

Insider Trading

No insider trading activity.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2023. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.